Clinica
Medtronic's Resolute Integrity enters US market with FDA greenlight
21 February 2012
Tina Tan
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- TCT 2011: Medtronic’s new-gen DES shows benefits for diabetics; Endeavor beats Boston’s Taxus at five years
- Abbott's next-generation Xience DES gets US FDA green light
- J&J exits from DES market as competition gets too heated; takes $600m earning hit with Cordis overhaul
- Heart stent firms may be hit by unfavourable study showing drugs as good – and cheaper – in stable patients
Other Informa News
EVENTS
